Market Place
Sourcing Support
Micro’s Generics Varenicline Tartrate Receives Approval in US
29 Oct 2025 //
FDA
Sciegen’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Novast’s Generics Drospirenone, Estradiol Receives Approval in Us
28 Oct 2025 //
FDA
Changzhou Pharm’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Macleods’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Taro’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Alkem’s Generics Ticagrelor Receives Approval in US
28 Oct 2025 //
FDA
Navinta’s Generics Sevelamer Carbonate Receives Approval in US
27 Oct 2025 //
FDA
Ajenat’s Generics Glycopyrrolate Receives Approval in US
27 Oct 2025 //
FDA
Carnegie’s Generics Lomustine Receives Approval in US
27 Oct 2025 //
FDA
Zenara’s Generics Tafamidis Receives Tentative Approval in Us
27 Oct 2025 //
FDA
Azurity’s Resniben Receives Tentative Approval in US
24 Oct 2025 //
FDA
Bayer Healthcare’s Lynkuet Receives Approval in US
24 Oct 2025 //
FDA
Sterinova’s Rocuronium Bromide Receives Approval in US
24 Oct 2025 //
FDA
Hikma’s Generics Atropine Sulfate Receives Approval in US
24 Oct 2025 //
FDA
MSN’s Generics Rivaroxaban Receives Approval in US
24 Oct 2025 //
FDA
Glaxosmithkline’s Biologics Blenrep Receives Approval in US
23 Oct 2025 //
FDA
Azurity’s Javadin Receives Approval in US
23 Oct 2025 //
FDA
Teva’s Generics Dalbavancin Hydrochloride Receives Approval in US
23 Oct 2025 //
FDA
Alkem’s Generics Bempedoic Acid Receives Tentative Approval in US
23 Oct 2025 //
FDA
Dr Reddys’s Generics Docosanol Receives Approval in US
23 Oct 2025 //
FDA
Royal Pharma’s Dehydrated Alcohol Receives Approval in US
23 Oct 2025 //
FDA
Caplin’s Generics Nicardipine HCl in NaCl Receives Approval in US
22 Oct 2025 //
FDA
Novitium Pharma’s Generics Lofexidine HCl Receives Approval in US
22 Oct 2025 //
FDA
Quagen’s Generics Aripiprazole Receives Approval in US
22 Oct 2025 //
FDA
Meitheal’s Contepo Receives Approval in US
22 Oct 2025 //
FDA
Taro’s Generics Trifarotene Receives Tentative Approval in US
21 Oct 2025 //
FDA
Micro’s Generics Proparacaine HCl Receives Approval in US
20 Oct 2025 //
FDA
Alkem Lab’s Generics Tolvaptan Receives Tentative Approval in US
17 Oct 2025 //
FDA
Glaukos’s Epioxa HD Receives Approval in US
17 Oct 2025 //
FDA
Glaukos’s Epioxa Receives Approval in US
17 Oct 2025 //
FDA
Novitium’s Generics Clomiphene Citrate Receives Approval in US
17 Oct 2025 //
FDA
Alembic’s Generics Triamcinolone Receives Approval in US
17 Oct 2025 //
FDA
Covis’s Ferabright Receives Approval in US
16 Oct 2025 //
FDA
BPI’s Generics Trimethobenzamide HCl Receives Approval in US
16 Oct 2025 //
FDA
Novast’s Generics Conjugated Estrogens Receives Approval in US
15 Oct 2025 //
FDA
Sino’s Generics Sitagliptin Receives Tentative Approval in US
15 Oct 2025 //
FDA
Macleods’s Dapagliflozin Receives Tentative Approval in US
15 Oct 2025 //
FDA
Cipla’s Generics Bictegravir Receives Tentative Approval in US
14 Oct 2025 //
FDA
Amneal’s Generics Epinephrine Receives Approval in US
14 Oct 2025 //
FDA
Ajanta’s Generics Dapagliflozin Receives Tentative Approval in US
14 Oct 2025 //
FDA
Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
10 Oct 2025 //
FDA
Rubicon’s Generics Chlorpromazine HCl Receives Approval in US
10 Oct 2025 //
FDA
Cipla’s Generics Emtricitabine Receives Tentative Approval in US
10 Oct 2025 //
FDA
Apotex’s Generics Cladribine Receives Tentative Approval in US
08 Oct 2025 //
FDA
Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US
08 Oct 2025 //
FDA
Alkem’s Generics Zirconium Receives Tentative Approval in US
08 Oct 2025 //
FDA
Qilu Pharm’s Generics Afatinib Receives Tentative Approval in US
08 Oct 2025 //
FDA
PTC Therapeutics’s Sephience Approved in Canada
07 Oct 2025 //
HEALTH CANADA
L Perrigo’s Generics Fexofenadin HCl Receives Approval in US
07 Oct 2025 //
FDA
Sandoz’s Generics Axitinib Receives Tentative Approval In US
07 Oct 2025 //
FDA
Amneal Pharms’s Generics Isotretinoin Receives Approval in US
07 Oct 2025 //
FDA
SQ Innovation’s Lasix Onyu Receives Approval In US
07 Oct 2025 //
FDA
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
Taro’s Generics Lamotrigine Receives Approval In US
07 Oct 2025 //
FDA
Alkem’s Generics Lidocaine Receives Approval in US
06 Oct 2025 //
FDA
Hetero’s Generics Olmesartan Medoxomil Receives Approval in US
06 Oct 2025 //
FDA
Lotus’s Generics Nintedanib Receives Tentative Approval In US
06 Oct 2025 //
FDA
Zydus Lifesciences’s Generics Deflazacort Receives Approval in US
03 Oct 2025 //
FDA
Accord’s Generics Clomiphene Citrate Receives Approval in US
03 Oct 2025 //
FDA
